Tactile Systems Technology, Inc. (TCMD)
NASDAQ: TCMD · Real-Time Price · USD
27.61
-0.61 (-2.16%)
At close: Feb 4, 2026, 4:00 PM EST
27.63
+0.02 (0.07%)
After-hours: Feb 4, 2026, 4:10 PM EST
TCMD Revenue
Tactile Systems Technology had revenue of $85.76M in the quarter ending September 30, 2025, with 17.32% growth. This brings the company's revenue in the last twelve months to $311.51M, up 9.28% year-over-year. In the year 2024, Tactile Systems Technology had annual revenue of $292.98M with 6.76% growth.
Revenue (ttm)
$311.51M
Revenue Growth
+9.28%
P/S Ratio
2.06
Revenue / Employee
$300,398
Employees
1,037
Market Cap
617.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 292.98M | 18.56M | 6.76% |
| Dec 31, 2023 | 274.42M | 27.64M | 11.20% |
| Dec 31, 2022 | 246.79M | 38.73M | 18.61% |
| Dec 31, 2021 | 208.06M | 20.93M | 11.18% |
| Dec 31, 2020 | 187.13M | -2.36M | -1.25% |
| Dec 31, 2019 | 189.49M | 45.74M | 31.82% |
| Dec 31, 2018 | 143.75M | 34.47M | 31.54% |
| Dec 31, 2017 | 109.28M | 24.74M | 29.26% |
| Dec 31, 2016 | 84.54M | 21.67M | 34.47% |
| Dec 31, 2015 | 62.87M | 15.14M | 31.71% |
| Dec 31, 2014 | 47.74M | 10.56M | 28.41% |
| Dec 31, 2013 | 37.18M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 844.60M |
| Avanos Medical | 699.90M |
| Bioventus | 563.83M |
| Cytek Biosciences | 196.83M |
| SI-BONE | 193.58M |
| Standard BioTools | 169.74M |
| Pacific Biosciences of California | 154.58M |
| NeuroPace | 94.86M |
TCMD News
- 1 day ago - Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026 - GlobeNewsWire
- 2 months ago - Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Tactile Systems Technology Analysts Increase Their Forecasts After Better-Than-Expected Q3 Earnings - Benzinga
- 3 months ago - Tactile Systems Technology, Inc. (TCMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema - GlobeNewsWire
- 3 months ago - Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025 - GlobeNewsWire
- 6 months ago - Tactile Systems Technology, Inc. (TCMD) Q2 2025 Earnings Call Transcript - Seeking Alpha